Outlicensing Opportunities for New Partners. Veriton Pharma is seeking to enhance its corporate offering by way of gaining marketing authorisations for selected products.
Veriton Pharma are now looking to out-licence these products outside of their core UK market to interested partners.
Veriton Pharma is currently seeking potential partners with an interest in the CNS sector to market and distribute an epilepsy medication within the EEA and potentially RoW, outside the UK/Australia/MEA.
If you would be interested in taking one of our products and putting through the licensing program within your country please send us a message using the contact us form to discuss outlicensing opportunities further.
Licensed Products
We are committed to developing licensed medicinal products that meet the specific needs of our patients. Veriton Pharma’s portfolio of prescription medicines stems from our team’s deep expertise in the field of epilepsy.